AMERISAFE, Inc. logo AMSF - AMERISAFE, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $34.00 DETAILS
HIGH: $34.00
LOW: $34.00
MEDIAN: $34.00
CONSENSUS: $34.00
UPSIDE: 1.34%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Moderate
Trading 39.4% below fair value
Current Price $33.55
Bear Case $44.96 34.0% upside ($44.96 - $33.55) / $33.55 = 34.0% ROTCE 15.3% → 4.00x TBV
Fair Value $55.36 65.0% upside ($55.36 - $33.55) / $33.55 = 65.0% ROTCE 20.5% → 4.00x TBV
Bull Case $71.96 114.5% upside ($71.96 - $33.55) / $33.55 = 114.5% ROTCE 23.5% → 4.00x TBV

Adjust Assumptions

20.5%
6.0%

Key Value Driver

ROTCE (20.5%) vs. cost of equity (6.0%)

Implied Market Multiple 2.72x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $34.00 from 6 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $55.36 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $34.00 (from 6 analysts). Our estimate is 79% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly